0591-3670
Generic: nabumetone
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
nabumetone
Labeler
actavis pharma, inc.
Dosage Form
TABLET, FILM COATED
Active Ingredients
nabumetone 500 mg/1
Identifiers & Regulatory
Product NDC
0591-3670
Product ID
0591-3670_1d6f0d61-13ba-4154-8cc3-4e4c17c0ebcc
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2011-06-13
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05913670
Hyphenated Format
0591-3670
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
nabumetone (source: label)
Generic Name
nabumetone (source: ndc)
Application Number
ANDA091083 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 500 mg/1
Packaging
- 15150 TABLET, FILM COATED in 1 BOX (0591-3670-00)
- 18180 TABLET, FILM COATED in 1 CONTAINER (0591-3670-77)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "1d6f0d61-13ba-4154-8cc3-4e4c17c0ebcc", "openfda": {}, "finished": false, "packaging": [{"description": "15150 TABLET, FILM COATED in 1 BOX (0591-3670-00)", "package_ndc": "0591-3670-00", "marketing_start_date": "13-JUN-11"}, {"description": "18180 TABLET, FILM COATED in 1 CONTAINER (0591-3670-77)", "package_ndc": "0591-3670-77", "marketing_start_date": "16-SEP-24"}], "product_id": "0591-3670_1d6f0d61-13ba-4154-8cc3-4e4c17c0ebcc", "dosage_form": "TABLET, FILM COATED", "product_ndc": "0591-3670", "generic_name": "Nabumetone", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "NABUMETONE", "strength": "500 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20110613", "listing_expiration_date": "20261231"}